Title:
【発明の名称】アダマンタン誘導体
Document Type and Number:
Japanese Patent JP2001525391
Kind Code:
A
Abstract:
The invention provides adamantane derivatives, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy.
Inventors:
Andrew Baxter
Blow, Stefan
Machinery, Thomas
Mochimore, michael
Cladding Boel, David
Blow, Stefan
Machinery, Thomas
Mochimore, michael
Cladding Boel, David
Application Number:
JP2000524257A
Publication Date:
December 11, 2001
Filing Date:
December 01, 1998
Export Citation:
Assignee:
AstraZeneca UK Limited
International Classes:
A61K31/16; A61K31/167; A61K31/381; A61K31/40; A61K31/403; A61K31/404; A61K31/4045; A61K31/416; A61K31/4164; A61K31/428; A61K31/44; A61K31/445; A61K31/4453; A61K31/52; A61K31/5375; A61P19/00; A61P19/02; A61P29/00; A61P37/06; C07C233/08; C07C233/15; C07C233/25; C07C233/26; C07C235/16; C07C237/04; C07C237/08; C07D209/04; C07D209/08; C07D209/14; C07D209/16; C07D213/40; C07D213/75; C07D221/22; C07D295/08; C07D231/54; C07D231/56; C07D233/60; C07D239/42; C07D277/62; C07D277/64; C07D295/092; C07D295/12; C07D295/135; C07D333/40; C07D473/34; C07D493/08; C07D521/00; (IPC1-7): C07C233/08; A61K31/167; A61K31/381; A61K31/40; A61K31/404; A61K31/4045; A61K31/416; A61K31/4164; A61K31/428; A61K31/44; A61K31/4453; A61K31/52; A61K31/5375; A61P19/02; A61P29/00; A61P37/06; C07C233/15; C07C233/26; C07C235/16; C07C237/04; C07D209/08; C07D209/14; C07D213/75; C07D231/56; C07D233/60; C07D239/42; C07D277/64; C07D295/08; C07D295/12; C07D333/40; C07D473/34; C07D493/08
Attorney, Agent or Firm:
Shusaku Yamamoto